Treatment Tailored to Your Biology

December 16, 2021 21 min

Rose Higgins, chief executive officer at HealthMyne, Inc., sits down with Sam to discuss the role radiomics is playing in cancer care. Our biology-guided radiotherapy will generate a plethora of new data that will one day become part of the data fabric to help us understand what is happening at both the molecular and biological level. This podcast dives into how radiomics can provide insights to better inform treatment decisions and what the future may hold.

  • Rose Higgins

    Chief Executive Officer, HealthMyne

  • Sam Mazin, PhD

    Founder and CTO, RefleXion

735-00094 Rev A